HLA-G is a non-classical major histocompatibility complex class I molecule
that differs from the classical HLA-A, -B and -C molecules by (i) alternati
ve splicing of mRNAs encoding for at least four membrane-bound and two solu
ble HLA-G isoforms, (ii) a limited polymorphism, and (iii) a tissue-restric
ted distribution. Studies over the past few years have elucidated the funct
ion of HLA-G demonstrating inhibition of both NK cell- and T cell-mediated
cytolysis. Furthermore, aside from its expression during pregnancy, we have
shown that HLA-G is also expressed in solid tumor cells (i.e. human melano
ma cell lines and ex vivo melanoma biopsies). Here we present a review of t
he current state of knowledge of the immunotolerant functions of HLA-G and
their implications in materno-fetal tolerance and tumor immunosurveillance.